跳至主要内容
临床试验/NCT04791852
NCT04791852已完成不适用

Potential Role of Donor-derived Cell-Free DNA as a Biomarker in Cardiac Allograft Vasculopathy

Puerta de Hierro University Hospital1 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2019年1月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
94
试验地点
1
主要终点
Performance of the biomarker for the diagnosis of CAV

研究概览

简要总结

Cross-sectional study. We will prospectively obtain ddcf-DNA levels in all patients who undergo routine coronary angiography > 1 year after HT. Our main goal is to evaluate the performance of Donor-derived Cell Free DNA (ddcf-DNA) as a biomarker of CAV.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 18 and under 80 years old, HT > 1 year ago

排除标准

  • Patients under 18 or over 80 years old
  • Multiorgan transplant
  • History of acute cellular rejection ≥ 1R or antibody mediated rejection in the previous 6 months
  • Concomitant infection by CMV

结局指标

主要结局

Performance of the biomarker for the diagnosis of CAV

时间窗: 2 years

Determine the performance of this biomarker in this situation using receiver-operator characteristics analysis.

Correlation between ddcf-DNA and CAV

时间窗: 2 years

Correlation between ddcf-DNA levels and the presence of any degree of CAV (CAV0 vs CAV1, 2, or 3)

次要结局

  • Correlation of ddcf-DNA with the different degrees of CAV (0, 1, 2 and 3)(2 years)
  • Correlation of ddcf-DNA with other biomarkers (NTproBNP and troponin I)(2 years)

研究者

发起方
Puerta de Hierro University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Javier Segovia Cubero

Head of Cardiology Department

Puerta de Hierro University Hospital

研究点 (1)

Loading locations...

相似试验